Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction

British Journal of Surgery

Volumn 86, Issue 11, 1999, Pages 1410-1414

  Kennedy, J A ^a   Lewis, H ^a   Clements, W D B ^a   Kirk, S J ^a   Campbell, G ^a   Halliday, M I ^a   Rowlands, B J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GADOLINIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; BLOOD LEVEL; CELL DAMAGE; CELL SECRETION; CONTROLLED STUDY; KUPFFER CELL; MALE; MORTALITY; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; SURVIVAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CHOLESTASIS; ENDOTOXINS; GADOLINIUM; KUPFFER CELLS; LIGATION; MALE; RATS; RATS, WISTAR; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032723336     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01269.x     Document Type: Article

References (17)

1. 1 Armstrong CP, Dixon JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg 1984; 71: 234-8.
2. 2 Sheridan WG, Williams HOL, Lewis MH. Morbidity and mortality of common bile duct exploration. Br J Surg 1987; 74: 1095-9.
3. 3 Lai ECS, Chu KM, Lo C-Y, Mok FPT, Fan S-T, Lo C-M et al. Surgery for malignant obstructive jaundice: analysis of mortality. Surgery 1992; 112: 891-6.
4. 4 Clements WDB, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ. The effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg 1993; 128: 200-5.
5. 5 Kennedy JA, Clements WDB, Halliday MI, Kirk SJ, Rowlands BJ. Paradoxical responses of Kupffer cells to experimental obstructive jaundice. Br J Surg 1994; 81: 1815 (Abstract).
6. 6 Campbell GR, Magee D, Kennedy A, Rowlands BJ, Halliday MI. An ELISA for measuring tumour necrosis factor α in rat plasma. Eur Cytokine Nerw 1997; 8: 97-102.
7. 7 Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54: 589-99.
8. 8 Wardle EN, Wright NA. Endotoxin and acute renal failure associated with obstructive jaundice. BMJ 1970; 4: 472-4.
9. 9 Diamond T, Dolan S, Thompson RLE, Rowlands BJ. Development and reversal of endotoxemia and endotoxin-related death in obstructive jaundice. Surgery 1990; 108: 370-5.
10. 10 Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin-1α, β and tumor necrosis factor during experimental endotoxemia. Kupffer cell expression, and glucocorticoid effects. Am J Pathol 1991; 138: 395-402.
11. 11 Husztik E, Lazar G, Parducz A. Electron microscopic study of Kupffer-cell phagocytosis blockade induced by gadolinium chloride. Br J Exp Pathol 1980; 61: 624-30.
12. 12 Hardonk MJ, Dijkhuis FWJ, Hulstaert CE, Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 1992; 52: 296-302.
13. 13 Rai RM, Zhang JX, Clemens MG, Diehl AM. Gadolinium chloride alters the acinar distribution of phagocytosis and balance between pro-and anti-inflammatory cytokines. Shock 1996; 6: 243-7.
14. 14 Louis H, Le Moine O, Peny M-O, Gulbis B, Nisol F, Goldman M et al. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 1997; 112: 935-42.
15. 15 Collier DStJ, Pain JA, Wight DGD, Lovat P, Bailey ME. The Kupffer cell in experimental extrahepatic cholestasis in the rat -a light microscopy, immunohistochemical and electron microscopy study. J Pathol 1986; 150: 187-94.
16. 16 Hines JE, Johnson SJ, Burt AD. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol 1993; 142: 511-18.
17. 17 Tracy TF Jr, Fox ES. CD14-lipopolysaccharide receptor activity in hepatic macrophages after cholestatic liver injury. Surgery 1995; 118: 371-7.